
68. Patient-focused Wet AMD, Nancy Lurker, President & CEO, Said Saim, CTO, EyePoint Pharmaceuticals
Nancy Lurker: President & Chief Executive Officer Our President, CEO, and a director since September 2016, Ms Lurker has broad-ranging experience in the pharmaceutical industry and a track record of m...
11 Aug 202128min

67. ML protein therapy, Mike Nally, CEO, and Geoff von Maltzahn, Co-Founder, Generate Biomedicines
Mike Nally is the Chief Executive Officer of Generate Biomedicines and a CEO-Partner at Flagship Pioneering. Mike brings significant experience leading global organizations and is passionate about wor...
4 Aug 202136min

66. I’ll take “Wild Rides” for 500, Alex: Biotech Entrepreneur’s Story, Ron Cohen, CEO, Acorda
Ron Cohen, M.D. is President, CEO and founder of Acorda Therapeutics, Inc., a public biotechnology company developing therapies for disorders of the nervous system, including multiple sclerosis, Parki...
28 Jul 202140min

65. Patient focused precision oncology, Avanish Vellanki, Cofounder and CEO, Rain Therapeutics
Avanish Vellanki is passionate about offering cancer patients better treatment options, and he firmly believes that precision oncology strategies are the best manner in which to achieve that goal. He ...
21 Jul 202129min

64. Tech-driven acceleration in clinical trials, Benjamine Liu, Co-founder and CEO, TrialSpark
Benjamine Liu is the co-founder and CEO of TrialSpark, a technology company that is reimagining drug development. Benjamine received his DPhil at Oxford as a Rhodes Scholar, conducting his work with ...
14 Jul 202127min

63. Building a leader in infectious diseases, Ankit Mahadevia, President and CEO, Spero Therapeutics
Ankit Mahadevia is the CEO of Spero Therapeutics and a member of the Board of Directors. He was formerly a Venture Partner in the life sciences group at Atlas Venture, located in Cambridge, MA. In tha...
7 Jul 202138min

62. Tackling autoimmune and allergic disease, Jonathan Rigby, Group CEO, Revolo Biotherapeutics
Jonathan Rigby is an experienced CEO with three decades of experience creating value and opportunities for companies in the pharmaceutical, biotech and drug delivery technology industry. He currently ...
23 Jun 202125min

61. Groundbreaking immunology microbe oral therapies, Simba Gill, CEO, Evelo Biosciences
Balkrishan (Simba) Gill, Ph.D. has served as our President, Chief Executive Officer and a member of our Board of Directors since September 2015. Dr. Gill also has served on the board of directors of R...
16 Jun 202140min



















